A/Prof Adam Wheatley
Principal Research Fellow
Department of Microbiology and Immunology
183 Scholarly works
38 Projects
HIGHLIGHTS
2026
Journal article
Delivery of monoclonal antibodies using mRNA lipid nanoparticles confers protection against SARS-CoV-2 and influenza
DOI: 10.1016/j.omtn.2026.1028732026
Journal article
Immune responses associated with protection from SARS-CoV-2 infection
DOI: 10.1016/j.vaccine.2026.1285792026
Journal article
IFN-gene signatures in B cells following influenza A and B virus infection and influenza vaccination
DOI: 10.1038/s44321-026-00395-82026
Journal article
Evaluating southern pigtail macaques as an immunological model for human antibody responses.
DOI: 10.1038/s41598-026-42695-62023
Research Grant
Biologics for the Prophylaxis and Treatment of COVID19
2023
Research grants (ARC, NHMRC, MRFF)
RNA Powered Antiviral Antibodies
2022
Research grants (ARC, NHMRC, MRFF)
Immune Responses to SARS-CoV-2 Variants Across Age Groups and Vulnerable Populations
RECENT SCHOLARLY WORKS
2026
Journal article
Immunodominance is a poor predictor of vaccine-induced T follicular helper cell quality
DOI: 10.1016/j.ebiom.2026.1061852026
Journal article
Age-related differences in mRNA vaccine immunogenicity and adjuvancy
DOI: 10.1111/imcb.701022026
Journal article
Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B viruses
DOI: 10.1126/scitranslmed.aea86212026
Journal article
Impact of serum versus anticoagulant-containing plasma on influenza virus neuraminidase-based serological assays
DOI: 10.1016/j.vaccine.2025.1279562026
Journal article
Elevated SARS-CoV-2 IgG4 in plasma and mucosa following repeated mRNA boosters impact antibody functions to Omicron and sarbecoviruses
DOI: 10.1016/j.ebiom.2025.1060872026
Journal article
Booster Immunisation with Skin-Patch-Delivered Unadjuvanted SARS-CoV-2 Spike Protein Vaccine Is Safe and Immunogenic in Healthy Adults
DOI: 10.3390/vaccines14010028
RECENT PROJECTS
2024
Research grants (ARC, NHMRC, MRFF)
Rational Improvement of Vaccines and Therapeutics for Pandemic Threats
2024
Research grants (ARC, NHMRC, MRFF)
A Mechanistic Approach to Next-Generation Vaccine Design